Ensysce Biosciences, Inc.
Ticker: 1716947
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.16+20.8% | 0.96+95.9% | 0.49-64.2% | 1.37+3.8% | 1.32-61.4% | 3.42+1800.0% | 0.18-41.9% | 0.31 |
| Total Income | 1.16+20.8% | 0.96+95.9% | 0.49-64.2% | 1.37+3.8% | 1.32-61.4% | 3.42+1800.0% | 0.18-41.9% | 0.31 |
| EXPENSES | ||||||||
| Expenditure | 3.74-17.3% | 4.52+6.9% | 4.23+35.6% | 3.12-5.2% | 3.29+18.8% | 2.77+29.4% | 2.14-0.5% | 2.15 |
| PROFIT | ||||||||
| Net Profit | -2.57+27.8% | -3.56+4.6% | -3.73-115.6% | -1.73+11.3% | -1.95-395.5% | 0.66+133.5% | -1.97+36.9% | -3.12 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-118.86pp | 18.86%+118.86pp | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-119.35pp | 19.36%+119.35pp | -100.00% | -100.00% |
| EPS | -0.20+61.5% | -0.52+59.7% | -1.29-63.3% | -0.79+43.2% | -1.39-2085.7% | 0.07+131.8% | -0.22+60.0% | -0.55 |
Corporate Events
Board MeetingENSC
20265Aug
Board Meeting
Acquisition of Cy Biopharma, Inc. and concurrent private pla…
SEC Filing ↗ Board MeetingENSC
202610Jul
Board Meeting
Jeffrey Millard resigned as Chief Operating Officer of Ensys…
SEC Filing ↗ Board MeetingENSC
20261Apr
Board Meeting
Director Resignation — Curtis Rosebraugh resigned from the B…
SEC Filing ↗